Mesothelin-Specific T-Cells (FH-TCR-Tᴍsʟɴ) for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma
Clinical trial NCT04809766 · TERMINATED
Trial details
- NCT number
- NCT04809766
- Sponsor
- Fred Hutchinson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-14
- Primary completion
- 2024-10-24
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.